Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2000 Dec;83(12):1688-95.
doi: 10.1054/bjoc.2000.1522.

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

S L Deming  1 , S J Nass, R B Dickson, B J Trock
Affiliations
Free PMC article
Meta-Analysis

C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance

S L Deming et al. Br J Cancer. 2000 Dec.
Free PMC article

Abstract

Data from basic research suggests that amplification of the proto-oncogene c-myc is important in breast cancer pathogenesis, but its frequency of amplification and prognostic relevance in human studies have been inconsistent. In an effort to clarify the clinical significance of c-myc amplification in breast cancer, we conducted a comprehensive literature search and a meta-analysis in which 29 studies were evaluated. The weighted average frequency of c-myc amplification in breast tumours was 15.7% (95% CI = 12.5-18.8%), although estimates in individual studies exhibited significant heterogeneity, P<0.0001. C-myc amplification exhibited significant but weak associations with tumour grade (RR = 1.61), lymph-node metastasis (RR = 1.24), negative progesterone receptor status (RR = 1.27), and postmenopausal status (RR = 0.82). Amplification was significantly associated with risk of relapse and death, with pooled estimates RR = 2.05 (95% CI = 1.51-2.78) and RR = 1.74 (95% CI = 1.27-2.39), respectively. This effect did not appear to be merely a surrogate for other prognostic factors. These results suggest that c-myc amplification is relatively common in breast cancer and may provide independent prognostic information. More rigorous studies with consistent methodology are required to validate this association, and to investigate its potential as a molecular predictor of specific therapy response.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Acta Oncol. 1993;32(3):289-94 - PubMed
    1. Cancer Res. 1993 Apr 15;53(8):1956-61 - PubMed
    1. Anticancer Res. 1993 Sep-Oct;13(5C):1895-900 - PubMed
    1. Jpn J Cancer Res. 1993 Nov;84(11):1159-64 - PubMed
    1. Cancer Res. 1994 Aug 15;54(16):4274-6 - PubMed

Publication types

-